Flagship Harbor Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Flagship Harbor Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,073	Closed	-$104K	–	1973
2020 Q3	$104K	Sell	1,073 -2	-0.2%	-$230	0.01%	651
2020 Q2	$131K	Buy	1,075 +200	+23%	+$22.7K	0.02%	571
2020 Q1	$77K	Sell	875 -558	-39%	-$59.1K	0.02%	645
2019 Q4	$150K	Buy	1,433 +268	+23%	+$30.1K	0.03%	506
2019 Q3	$134K	Buy	1,165 +30	+3%	+$4.55K	0.03%	514
2019 Q2	$195K	Buy	1,135 +32	+3%	+$5.54K	0.04%	400
2019 Q1	$185K	Buy	1,103 +7	+0.6%	+$1.04K	0.04%	420
2018 Q4	$106K	Buy	1,096 +8	+0.7%	+$1.05K	0.03%	497
2018 Q3	$182K	Buy	1,088 +300	+38%	+$43.3K	0.03%	440
2018 Q2	$109K	Buy	+788	New	+$112K	0.02%	557

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Flagship Harbor Advisors's GWPH Position: Q4 2020 in Review

Flagship Harbor Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2020, closing a stake of 1,073 shares — an estimated $104K sold.

Flagship Harbor Advisors first reported a position in GWPH in Q2 2018 and held it in 10 quarters. The position peaked at $195K in Q2 2019. 279 funds tracked by Wall St. Rank hold GWPH as of Q4 2020.

Flagship Harbor Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2020 after selling out during the quarter.
Flagship Harbor Advisors sold 1,073 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2020, an estimated $104K.
Flagship Harbor Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2018 and held it in 10 quarters.
Flagship Harbor Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $195K in Q2 2019.
279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2020.

Based on Flagship Harbor Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.